More on ACRS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.50 |
|
|||
| Open | $4.55 | ||||
| 52 Wk High | $33.88 | ||||
| 52 Wk Low | $14.12 | ||||
| Day High | $4.93 | ||||
| Day Low | $4.50 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,819,281 | ||||
- Form 4 Aclaris Therapeutics, For: Jun 04 Filed by: Molineaux Christopher P.
- Form 4 Aclaris Therapeutics, For: Jun 04 Filed by: MILANO VINCENT
- Form 4 Aclaris Therapeutics, For: Jun 04 Filed by: Mehra Anand
- Form 4 Aclaris Therapeutics, For: Jun 04 Filed by: Humphries William D.
- Form 4 Aclaris Therapeutics, For: Jun 04 Filed by: SCHIFF ANDREW N
- Form 4 Aclaris Therapeutics, For: Jun 04 Filed by: GOWEN MAXINE
- Form 8-K Aclaris Therapeutics, For: Jun 04
- Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
- Form SCHEDULE 13G/A Aclaris Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
- Aclaris Therapeutis (ACRS) PT Raised to $4 at Stifel
Entities mentioned with ACRS
- FDA | View Related Stories »
- 13G | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Jefferies & Co | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
